Shares in Ultracharge surge on back of Epsilor licensing agreement
Published 03-AUG-2017 13:11 P.M.
|
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Shares in battery technology group, UltraCharge (ASX: UTR) have traded strongly in August, increasing 30% from 2.3 cents at the end of July to hit an intraday high of 3 cents on Wednesday.
Of course, it should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
This appeared to be partly driven by positive developments announced in the company’s quarterly report which was released on July 28. However, news released on Thursday morning in relation to an exclusive license agreement for new battery intellectual property triggered another surge.
Before discussing this most recent development, it is important to understand UTR’s current position. The company is based in Israel and has acquired exclusive rights to patented technology from the Nanyang Technology University in Singapore (NTU).
The technology will replace graphite in anodes (negative pole) with a nanotube gel material made from titanium dioxide, in lithium batteries. This technology has the potential to revolutionise the market for lithium batteries by producing a battery that is not only safe with a fast charging period, but also offers a longer lifetime.
Having established a laboratory facility in Israel to conduct nanotube synthesis and fabrication of the nanotube anode, UTR is discussing supply options with end users in the global battery market.
Acquisition of license agreement boosts research capacity
The licensing agreement announced today between UTR and Epsilor Electric Fuel provides UTR with an exclusive license option for new battery intellectual property, and the company has also entered into an agreement with the group for the lease of its research facilities and the hire of specialised equipment, allowing it to expand its research team with additional resources.
By way of background, Epsilor is a subsidiary of Arotech Corporation’s (NASDAQ: ARTX) power sources division, which consists of the Epsilor-electric fuel facilities in Israel and UEC in South Carolina.
As part of the agreement, UTR will have the opportunity to expand its intellectual property portfolio with the option to purchase 100% of all rights and title in Epsilor’s intellectual property.
This will provide further assistance in the company pursuing its goal of efficiently producing nanotube material and increasing the density capacity of the materials which determine battery size.
In commenting on the license agreement, UTR’s Chief Executive Kobe Ben-Shabat said, “This exclusive license agreement over Epsilor’s intellectual property is an exciting opportunity for UTR to diversify its product offerings in energy storage solutions, as well as allowing us to expand our resources in terms of facilities, equipment and expertise which will enable us to fast track delivery of our current research programs in developing a world-class lithium battery using nanofiber materials.”
In collaboration with Leclanche, UTR will conduct a pilot project to test and evaluate its technology with a view to developing a cost competitive and large-scale manufacture of a high-cycling, fast charging and high energy density battery aimed at the Electric Vehicle market.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
